GW0742 – Powder, 1g
$79.99
-
GW0742 – Powder, 1g is ultra-pure, analytical-grade peroxisome proliferator-activated receptor delta (PPARδ/β) agonist with ≥98% purity, designed for in vitro/in vivo metabolic research and analytical testing. This lyophilized material functions as a potent, highly selective PPARδ agonist with an EC₅₀ of 1 nM for human PPARδ and 1000-fold selectivity over PPARα (EC₅₀ = 1.1 μM) and PPARγ (EC₅₀ = 2 μM), activating fatty acid oxidation pathways, enhancing lipid metabolism, and improving glucose homeostasis, making it invaluable for investigators studying obesity, metabolic syndrome, diabetes, cardiovascular disease, inflammation, pancreatitis, hypertension in diet-induced obese mice, and lipid metabolism regulation. Available for fast, compliant shipping to all U.S. states and European countries via dedicated logistics hubs.
-
Third-party certified lot coding with publicly available COA (Certificate of Analysis) for absolute purity transparency
-
Formulation completely free of adulterants, excipients, flow agents, and other compounds to guarantee raw chemical purity
-
Precision over-weighed by 5-10% inside vessel to compensate for natural adhesion loss during laboratory powder transfer
-
UV-resistant PET single-wall jar with tamper-proof seal engineered for transit safety and chemical stability
-
GW0742 – Powder, 1g
This premium, laboratory-grade research compound delivers ultra-pure raw GW0742 powder at ≥98% purity, representing the highest standard for modern scientific investigations into PPARδ/β receptor activation and metabolic regulation mechanisms. The lyophilized crystalline powder form provides investigators with a single-compound reference standard ideal for analytical testing, in vitro cell culture modeling of metabolic pathways, and in vivo preclinical research applications where precise GW0742 isolation is critical for studying lipid metabolism enhancement, fatty acid oxidation, and glucose homeostasis.
All shipments to the 50 United States are fulfilled directly from primary U.S. production facilities, ensuring 2-5 business day delivery nationwide. International orders to the United Kingdom and continental Europe are processed through our dedicated United Kingdom shipping hub, which streamlines customs clearance and reduces transit times across all European countries. This dual-hub logistics infrastructure guarantees seamless, compliant delivery while maintaining chemical integrity throughout transit.
-
Public third-party lab reports with unique lot-coding ensure absolute transparency for every batch sold
-
Formulation contains zero adulterants, excipients, flow agents, or contaminants—pure GW0742 only
-
Strategic over-weighing compensates for powder adhesion loss, guaranteeing minimum 1g recoverable material
-
PET single-wall jar features UV-resistant construction and tamper-proof seal for transit safety
Technical Specifications & Chemical Profile
| Chemical Property | Specification Data |
|---|---|
| Product Name | GW0742 – Powder, 1g |
| Common Synonyms | GW-0742, GW 0742, GW610742, Fitorine, PPARδ Agonist GW0742, PPAR-B Agonist |
| CAS Number | 317318-84-6 |
| Molecular Formula | C₂₁H₁₇F₄NO₃S₂ |
| Molar Mass | 471.49 g/mol |
| Primary Target Mechanism | Potent and highly selective PPARβ/δ (PPARδ) agonist; EC₅₀ = 1 nM for human PPARδ; IC₅₀ = 1 nM in binding assay; 1000-fold selectivity over PPARα (EC₅₀ = 1.1 μM) and PPARγ (EC₅₀ = 2 μM); activates fatty acid beta-oxidation; enhances lipid metabolism; improves glucose homeostasis; mixed PPAR-β agonist/antagonist depending on dosage; antagonistic at androgen receptors and VDR; weak activity on multiple nuclear receptors; anti-inflammatory effects; ameliorates experimentally induced pancreatitis in mice; prevents hypertension in diet-induced obese mice; potential antidiabetic drug; increases HDL cholesterol; orange adipose tissue browning; reduces inflammation; metabolic regulation |
| Physical Form | White crystalline powder (lyophilized) |
Research Applications & Storage Protocols
PPARδ Agonism & Lipid Metabolism Enhancement Profiling
GW0742 (GW-0742, GW610742, Fitorine) functions as a synthetic, potent, and highly selective PPARβ/δ agonist developed by GlaxoSmithKline, representing one of the most selective PPARδ agonists available for research. The compound is a potent PPARβ and PPARδ agonist with an EC₅₀ of 1 nM for human PPARδ and an IC₅₀ of 1 nM in binding assays, demonstrating approximately 1000-fold selectivity over PPARα (EC₅₀ = 1.1 μM) and PPARγ (EC₅₀ = 2 μM). GW0742 activates fatty acid beta-oxidation pathways and enhances lipid metabolism, improving glucose homeostasis through PPARδ-mediated transcriptional regulation. Interestingly, GW0742 functions as a dual PPAR-β agonist and antagonist depending on the dosage administered, with weak activity on multiple nuclear receptors and antagonistic effects at androgen receptors and vitamin D receptor (VDR). The compound has been shown to ameliorate experimentally induced pancreatitis in mice, demonstrating therapeutic potential for inflammatory conditions. Additionally, GW0742 prevents hypertension in diet-induced obese mice and has been investigated as a potential antidiabetic drug due to its anti-inflammatory effects and metabolic regulation capabilities. The compound increases HDL cholesterol and promotes orange adipose tissue browning, contributing to improved metabolic health and lipid metabolism. This PPARδ agonist mechanism positions GW0742 as a critical tool compound for investigating obesity research, metabolic syndrome studies, diabetes mechanisms, cardiovascular disease pathways, inflammation research, pancreatitis models, hypertension in obese populations, and lipid metabolism regulation in preclinical models, offering potential therapeutic insights for metabolic disorders.
Handling & Storage Guidelines
-
Long-Term Storage: Store at -20°C (-4°F) for optimal stability (up to 3 years); stable at room temperature for short-term storage. Protect from light and moisture; store in a cool, dry place in airtight conditions; melting point: 134.5-135.5°C
-
Solubility: DMSO: 250 mg/mL (530.23 mM), sonication recommended; >5 mg/mL in DMSO; Ethanol: soluble; Water: insoluble (<1 mg/mL); DMF: 25 mg/mL; In Vivo formulation: 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline at 2 mg/mL (4.24 mM), sonication recommended, dissolve by heating/sonication if necessary
-
Appearance: White crystalline powder; clear solutions in DMSO and ethanol; insoluble in aqueous solutions
Global Logistics & Order Fulfillment
We proudly support scientific advancement across all 50 U.S. states and throughout Europe. Customers can seamlessly toggle their preferred currency between USD and EUR using the currency switcher located on the left-hand side of our website. All shipments are securely packaged to withstand international transit without compromising structural or chemical stability.
Laboratory Use Only Disclaimer
This material is sold strictly for laboratory research and development use only. It is not approved for human consumption, nor for medical, veterinary, or household applications. All purchases are governed by our standard Terms & Conditions. Please review them carefully before placing your order.
| pa_feature |
Discountinued |
|---|---|
| pa_form |
Powders |
You must be logged in to post a review.


Reviews
There are no reviews yet.